Total Assets Summary of Novartis AG

Novartis AG's latest annual total assets in 2023 was 99.94 Billion USD , down -14.91% from previous year.
Novartis AG's latest quarterly total assets in 2024 Q3 was 103.52 Billion USD , up 6.17% from previous quarter.
Novartis AG reported annual total assets of 117.45 Billion USD in 2022, down -10.88% from previous year.
Novartis AG reported annual total assets of 131.79 Billion USD in 2021, down -0.2% from previous year.
Novartis AG reported quarterly total assets of 103.52 Billion USD for 2024 Q3, up 6.17% from previous quarter.
Novartis AG reported quarterly total assets of 94.33 Billion USD for 2024 Q1, down -5.61% from previous quarter.

Annual Total Assets Chart of Novartis AG (2023 - 1998)

Historical Annual Total Assets of Novartis AG (2023 - 1998)

Year	Total Assets	Total Assets Growth
2023	99.94 Billion USD	-14.91%
2022	117.45 Billion USD	-10.88%
2021	131.79 Billion USD	-0.2%
2020	132.05 Billion USD	11.56%
2019	118.37 Billion USD	-18.68%
2018	145.56 Billion USD	9.38%
2017	133.07 Billion USD	2.27%
2016	130.12 Billion USD	-1.09%
2015	131.55 Billion USD	4.92%
2014	125.38 Billion USD	-0.69%
2013	126.25 Billion USD	1.64%
2012	124.21 Billion USD	5.72%
2011	117.49 Billion USD	-4.72%
2010	123.31 Billion USD	29.12%
2009	95.5 Billion USD	21.97%
2008	78.29 Billion USD	3.77%
2007	75.45 Billion USD	10.95%
2006	68 Billion USD	17.8%
2005	57.73 Billion USD	5.99%
2004	54.46 Billion USD	10.45%
2003	49.31 Billion USD	9.24%
2002	45.14 Billion USD	12.01%
2001	40.3 Billion USD	13.59%
2000	35.48 Billion USD	-13.9%
1999	41.21 Billion USD	2.48%
1998	40.21 Billion USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	97.5 Billion USD	3.36%
2024 Q3	103.52 Billion USD	6.17%
2024 Q1	94.33 Billion USD	-5.61%
2023 FY	99.94 Billion USD	-14.91%
2023 Q4	99.94 Billion USD	-11.32%
2023 Q2	110.97 Billion USD	-1.12%
2023 Q1	112.24 Billion USD	-4.44%
2023 Q3	112.69 Billion USD	1.55%
2022 Q3	118.46 Billion USD	-3.62%
2022 FY	117.45 Billion USD	-10.88%
2022 Q4	117.45 Billion USD	-0.85%
2022 Q2	122.91 Billion USD	-1.84%
2022 Q1	125.21 Billion USD	-4.99%
2021 Q1	121.75 Billion USD	-7.8%
2021 FY	131.79 Billion USD	-0.2%
2021 Q4	131.79 Billion USD	8.73%
2021 Q3	121.2 Billion USD	-2.26%
2021 Q2	124.01 Billion USD	1.86%
2020 Q2	123.76 Billion USD	0.54%
2020 Q1	123.09 Billion USD	3.99%
2020 Q3	129.67 Billion USD	4.78%
2020 Q4	132.05 Billion USD	1.84%
2020 FY	132.05 Billion USD	11.56%
2019 Q1	137.94 Billion USD	-5.23%
2019 FY	118.37 Billion USD	-18.68%
2019 Q3	115.97 Billion USD	-0.28%
2019 Q4	118.37 Billion USD	2.07%
2019 Q2	116.29 Billion USD	-15.7%
2018 Q1	135.52 Billion USD	1.84%
2018 FY	145.56 Billion USD	9.38%
2018 Q4	145.56 Billion USD	1.8%
2018 Q3	142.99 Billion USD	0.66%
2018 Q2	142.05 Billion USD	4.82%
2017 Q3	134.97 Billion USD	0.91%
2017 Q4	133.07 Billion USD	-1.4%
2017 FY	133.07 Billion USD	2.27%
2017 Q1	131.98 Billion USD	1.43%
2017 Q2	133.74 Billion USD	1.34%
2016 Q1	132.44 Billion USD	0.68%
2016 FY	130.12 Billion USD	-1.09%
2016 Q2	131.43 Billion USD	-0.76%
2016 Q3	134 Billion USD	1.96%
2016 Q4	130.12 Billion USD	-2.9%
2015 Q2	135.41 Billion USD	0.35%
2015 Q3	132.92 Billion USD	-1.84%
2015 Q1	134.93 Billion USD	7.61%
2015 FY	131.55 Billion USD	4.92%
2015 Q4	131.55 Billion USD	-1.03%
2014 Q3	125.37 Billion USD	-0.31%
2014 Q1	125.33 Billion USD	-0.73%
2014 FY	125.38 Billion USD	-0.69%
2014 Q4	125.38 Billion USD	0.01%
2014 Q2	125.76 Billion USD	0.35%
2013 Q1	121.01 Billion USD	-2.58%
2013 Q2	121.07 Billion USD	0.05%
2013 FY	126.25 Billion USD	1.64%
2013 Q3	124.59 Billion USD	2.91%
2013 Q4	126.25 Billion USD	1.33%
2012 Q1	119.41 Billion USD	1.63%
2012 Q2	118.49 Billion USD	-0.77%
2012 Q3	121.21 Billion USD	2.3%
2012 Q4	124.21 Billion USD	2.47%
2012 FY	124.21 Billion USD	5.72%
2011 Q3	121.37 Billion USD	-3.6%
2011 FY	117.49 Billion USD	-4.72%
2011 Q4	117.49 Billion USD	-3.2%
2011 Q2	125.91 Billion USD	-1.02%
2011 Q1	127.21 Billion USD	3.16%
2010 Q3	124.62 Billion USD	28.58%
2010 Q2	96.92 Billion USD	1.18%
2010 FY	123.31 Billion USD	29.12%
2010 Q4	123.31 Billion USD	-1.05%
2010 Q1	95.79 Billion USD	0.3%
2009 Q3	90.68 Billion USD	7.61%
2009 Q4	95.5 Billion USD	5.31%
2009 FY	95.5 Billion USD	21.97%
2009 Q2	84.27 Billion USD	8.09%
2009 Q1	77.97 Billion USD	-0.42%
2008 Q1	76.31 Billion USD	1.15%
2008 Q3	82.02 Billion USD	-1.65%
2008 Q4	78.29 Billion USD	-4.54%
2008 FY	78.29 Billion USD	3.77%
2008 Q2	83.39 Billion USD	9.28%
2007 Q1	68.32 Billion USD	0.46%
2007 Q2	70.62 Billion USD	3.36%
2007 FY	75.45 Billion USD	10.95%
2007 Q4	75.45 Billion USD	-1.93%
2007 Q3	76.93 Billion USD	8.94%
2006 Q3	66.86 Billion USD	1.42%
2006 Q2	65.92 Billion USD	12.03%
2006 Q1	58.84 Billion USD	1.93%
2006 FY	68 Billion USD	17.8%
2006 Q4	68 Billion USD	1.71%
2005 Q1	49.64 Billion USD	-8.85%
2005 Q4	57.73 Billion USD	5.6%
2005 Q2	53.04 Billion USD	6.84%
2005 Q3	54.67 Billion USD	3.07%
2005 FY	57.73 Billion USD	5.99%
2004 Q4	54.46 Billion USD	9.95%
2004 Q1	48.26 Billion USD	-2.13%
2004 Q2	48.63 Billion USD	0.76%
2004 FY	54.46 Billion USD	10.45%
2004 Q3	49.53 Billion USD	1.86%
2003 Q3	46.32 Billion USD	1.52%
2003 Q2	45.63 Billion USD	-2.2%
2003 Q4	49.31 Billion USD	6.45%
2003 FY	49.31 Billion USD	9.24%
2003 Q1	46.66 Billion USD	3.36%
2002 Q2	43.07 Billion USD	0.0%
2002 FY	45.14 Billion USD	12.01%
2002 Q4	45.14 Billion USD	9.8%
2002 Q3	41.11 Billion USD	-4.55%
2001 Q2	34.47 Billion USD	0.0%
2001 FY	40.3 Billion USD	13.59%
2001 Q4	40.3 Billion USD	0.0%
2000 Q4	35.48 Billion USD	0.0%
2000 FY	35.48 Billion USD	-13.9%
2000 Q2	38.74 Billion USD	0.0%
1999 FY	41.21 Billion USD	2.48%
1998 FY	40.21 Billion USD	0.0%

Peer Total Assets Comparison of Novartis AG

Name	Total Assets	Total Assets Difference
AbbVie Inc.	134.71 Billion USD	25.808%
Bristol-Myers Squibb Company	95.15 Billion USD	-5.029%
Bristol-Myers Squibb Company Ce	95.15 Billion USD	-5.029%
Johnson & Johnson	167.55 Billion USD	40.352%
Eli Lilly and Company	64 Billion USD	-56.149%
Merck & Co., Inc.	106.67 Billion USD	6.309%
Organon & Co.	12.05 Billion USD	-728.869%
Pfizer Inc.	226.5 Billion USD	55.874%

Global Stocks Search

Novartis AG (NVS)

Total Assets Summary of Novartis AG

Annual Total Assets Chart of Novartis AG (2023 - 1998)

Historical Annual Total Assets of Novartis AG (2023 - 1998)

Peer Total Assets Comparison of Novartis AG